Evidence map›Paper›PMID 36580087›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2023

CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer: a single institute pilot study.

Andrei Fodor, Martina Mori, Roberta Tummineri, Sara Broggi, Chiara Lucrezia Deantoni, Paola Mangili, Simone Baroni, Stefano Lorenzo Villa, Italo Dell'Oca, Antonella Del Vecchio and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Andrei FodorDepartment of Radiation Oncology, IRCCS San Raffaele Scientific Institute, 60, Olgettina Street, 20132, Milan, Italy. fodor.andrei@hsr.it.ORCID 0000-0002-9285-4390
Martina MoriMedical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Roberta TummineriDepartment of Radiation Oncology, IRCCS San Raffaele Scientific Institute, 60, Olgettina Street, 20132, Milan, Italy.
Sara BroggiMedical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Chiara Lucrezia DeantoniDepartment of Radiation Oncology, IRCCS San Raffaele Scientific Institute, 60, Olgettina Street, 20132, Milan, Italy.
Paola MangiliMedical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Simone BaroniDepartment of Radiation Oncology, IRCCS San Raffaele Scientific Institute, 60, Olgettina Street, 20132, Milan, Italy.
Stefano Lorenzo VillaDepartment of Radiation Oncology, IRCCS San Raffaele Scientific Institute, 60, Olgettina Street, 20132, Milan, Italy.
Italo Dell'OcaDepartment of Radiation Oncology, IRCCS San Raffaele Scientific Institute, 60, Olgettina Street, 20132, Milan, Italy.
Antonella Del VecchioMedical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Claudio FiorinoMedical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Nadia Di MuzioDepartment of Radiation Oncology, IRCCS San Raffaele Scientific Institute, 60, Olgettina Street, 20132, Milan, Italy.
Vita-Salute San Raffaele University · IT

Funding

Associazione Italiana per la Ricerca sul Cancro IG23150
6 · The paper itself

Abstract

objectivesTo assess the potential of radiomic features (RFs) extracted from simulation computed tomography (CT) images in discriminating local progression (LP) after stereotactic body radiotherapy (SBRT) in the management of lung oligometastases (LOM) from colorectal cancer (CRC). MATERIALS AND

methodsThirty-eight patients with 70 LOM treated with SBRT were analyzed. The largest LOM was considered as most representative for each patient and was manually delineated by two blinded radiation oncologists. In all, 141 RFs were extracted from both contours according to IBSI (International Biomarker Standardization Initiative) recommendations. Based on the agreement between the two observers, 134/141 RFs were found to be robust against delineation (intraclass correlation coefficient [ICC] > 0.80); independent RFs were then assessed by Spearman correlation coefficients. The association between RFs and LP was assessed with Mann-Whitney test and univariate logistic regression (ULR): the discriminative power of the most informative RF was quantified by receiver-operating characteristics (ROC) analysis through area under curve (AUC).

resultsIn all, 15/38 patients presented LP. Median time to progression was 14.6 months (range 2.4-66 months); 5/141 RFs were significantly associated to LP at ULR analysis (p < 0.05); among them, 4 RFs were selected as robust and independent: Statistical_Variance (AUC = 0.75, p = 0.002), Statistical_Range (AUC = 0.72, p = 0.013), Grey Level Size Zone Matrix (GLSZM) _zoneSizeNonUniformity (AUC = 0.70, p = 0.022), Grey Level Dependence Zone Matrix (GLDZM) _zoneDistanceEntropy (AUC = 0.70, p = 0.026). Importantly, the RF with the best performance (Statisical_Variance) is simply representative of density heterogeneity within LOM.

conclusionFour RFs extracted from planning CT were significantly associated with LP of LOM from CRC treated with SBRT. Results encourage further research on a larger population aiming to define a usable radiomic score combining the most predictive RFs and, possibly, additional clinical features.

Indexed as

Colorectal NeoplasmsLung NeoplasmsRadiosurgeryHumansLungPilot ProjectsRecurrenceRetrospective StudiesTomography, X-Ray ComputedColorectal tumorsLocal control thoracic metastasesPlanning computed tomography (CT)Radical radiotherapyRadiomic features (RFs)

Identifiers

PMID36580087
OpenAlexW4313279773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.